© 1999 Cancer Research Campaign Article no. bjoc.1999.0651 Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Novel sulindac derivatives for colorectal cancer chemoprevention that target cGMP phosphodiesterases to suppress Wnt/β-catenin transcriptional activity

  2023cites this paper
• Association between aspirin use and lung cancer incidence depends on high-frequency use, bodyweight, and age in U.S. adults

  2021cites this paper
• In vitro evaluation of leishmanicidal properties of a new family of monodimensional coordination polymers based on diclofenac ligand

  2020cites this paper
• Nonsteroidal anti‐inflammatory drugs but not aspirin are associated with a lower risk of post‐colonoscopy colorectal cancer

  2020cites this paper
• 2010

  2019cites this paper
• The systematic case-referent method.

  2019cites this paper
• Effects of Colorectal Cancer Risk Factors on the Association Between Aspirin and Colorectal Cancer

  2019cites this paper
• Competing risks modeling of cumulative effects of time-varying drug exposures

  2019cites this paper
• Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin

  2018cites this paper
• SerumInterleukin-6,Insulin,andHOMA-IRinMaleIndividuals with Colorectal Adenoma

  2017cites this paper
• Inhibitory Effect of Aspirin on Cholangiocarcinoma Cells

  2017cites this paper
• Rôle de la consommation d'Anti-inflammatoires Non Stéroïdiens (AINS) dans la survenue du cancer de la prostate, du sein, et colorectal en France

  2017cites this paper
• Preparation and Characterization of Colon-Specific Microspheres of Diclofenac for Colorectal Cancer

  2015cites this paper
• Ibuprofen in the Prevention and Therapy of Cancer

  2015cites this paper
• Immune Modulation by Agents Used in the Prevention and Treatment of Colon and Pancreatic Cancers

  2015cites this paper
• Adult genetic risk screening.

  2014cites this paper
• Examples of Automated Databases

  2013cites this paper
• Lack of association between the interleukin 6 gene -174G>C polymorphism and colorectal cancer: evidence from a meta-analysis.

  2013cites this paper
• Modeling exposure–lag–response associations with distributed lag non-linear models

  2013cites this paper
• A novel copper(II) mononuclear complex with the non-steroidal anti-inflammatory drug diclofenac: structural characterization and biological activity.

  2013cites this paper
• NSAIDs and Gastrointestinal Cancer Prevention

  2012cites this paper
• Flexible marginal structural models for survival analysis

  2012cites this paper
• Mechanistic Investigation of Tolfenamic Acid, Betulinic Acid, and Aspirin in Anti-Cancer Therapy

  2012cites this paper
• The risks and benefits of prophylactic aspirin in vascular disease and cancer

  2012cites this paper
• Fundamentals of classification and regression trees

  2012cites this paper
• Prevention by Aspirin of Colorectal Adenoma Recurrence: Some Advances and Latest Results of the APACC Trial

  2011cites this paper
• Comparison of the pharmacokinetic and pharmacodynamic profiles of resveratrol at dietary and pharmacological doses

  2011cites this paper
• Aspirin, Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and Pancreatic Cancer Risk: a Clinic-Based Case–Control Study

  2011cites this paper
• Non-steroidal anti-inflammatory drugs and cancer, with an especial focus on esophageal cancer.

  2011cites this paper
• Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial

  2011cites this paper
• Effect of probiotics on aspirin-induced gastric mucosal lesions.

  2011cites this paper
• Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort

  2011cites this paper
• Circulating IL-6 level and presence of colorectal adenoma 1

  2011cites this paper
• Serum Interleukin-6, Insulin, and HOMA-IR in Male Individuals with Colorectal Adenoma

  2011cites this paper
• Oligodeoxyribozymes That Cleave β-Catenin Messenger RNA Inhibit Growth of Colon Cancer Cells via Reduction of β-Catenin Response Transcription

  2010cites this paper
• Non-Steroidal Anti-Inflammatory Drug Use and Colorectal Polyps in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

  2010cites this paper
• Primary prevention of colorectal cancer.

  2010cites this paper
• Tumor markers and rectal cancer: Support for an inflammation‐related pathway

  2009cites this paper
• Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study

  2009cites this paper
• A Preliminary Study on the Postoperative Survival of Patients Given Aspirin After Resection for Squamous Cell Carcinoma of the Esophagus or Adenocarcinoma of the Cardia

  2009cites this paper
• Flexible modeling of the cumulative effects of time‐dependent exposures on the hazard

  2009cites this paper
• Convergence of Hormones, Inflammation, and Energy-Related Factors: A Novel Pathway of Cancer Etiology

  2009cites this paper
• The effect of aspirin in the recurrence of colorectal adenomas: a meta‐analysis of randomized controlled trials

  2009cites this paper
• Aspirin, salicylates, and cancer.

  2009cites this paper
• Validating a method that deals with missing drug information in the Saskatchewan Drug Plan database

  2009cites this paper
• Aspirin and NSAIDs for the prevention of colorectal cancer.

  2009cites this paper
• Metabolomics in biomarker discovery: future uses for cancer prevention.

  2008cites this paper
• Contribution Use of Nonsteroidal Antiinflammatory Drugs and Distal Large Bowel Cancer in Whites and African Americans

  2008cites this paper
• Risk of breast cancer in relation to antibiotic use

  2008cites this paper
• Aspirin dose and duration of use and risk of colorectal cancer in men.

  2008cites this paper
• Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions.

  2008cites this paper
• Riesgo de cáncer colorrectal asociado a medicamentos: estudio de casos y controles

  2007cites this paper
• Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency

  2007cites this paper
• Polyamine metabolism and cancer prevention.

  2007cites this paper
• Individual and joint use of statins and low‐dose aspirin and risk of colorectal cancer: A population‐based case–control study

  2007cites this paper
• Nonsteroidal Anti-Inflammatory Drugs and Lung Cancer Risk: A Population-Based Case Control Study

  2007cites this paper
• Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer.

  2007cites this paper
• Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene–environment interaction?

  2007cites this paper
• Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

  2007influential citation
• IL6 genotypes and colon and rectal cancer

  2007cites this paper
• Regulation of COX and LOX by curcumin.

  2007cites this paper
• Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

  2007cites this paper
• Regular analgesic use and risk of multiple myeloma.

  2007cites this paper
• Use of Aspirin and NSAIDs to Prevent Colorectal Cancer

  2007cites this paper
• Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer–like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression

  2006cites this paper
• Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.

  2006cites this paper
• Association between Nonsteroidal Anti-inflammatory Drug Use and the Incidence of Lung Cancer in the Iowa Women's Health Study

  2006cites this paper
• Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries.

  2006cites this paper
• Nonsteroidal Anti-inflammatory Drugs and Subsite-Specific Colorectal Cancer Incidence in the Iowa Women's Health Study

  2006cites this paper
• Cytokines, NF-κB, Microenvironment, Intestinal Inflammation and Cancer

  2006cites this paper
• Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia.

  2006cites this paper
• The role of COX-2 in chemoprevention of colorectal cancer: A friend or an enemy?

  2006cites this paper
• COX-2 Polymorphism, Use of Nonsteroidal Anti-Inflammatory Drugs, and Risk of Colon Cancer in African Americans (United States)

  2006cites this paper
• In vitro-Evaluation kombinierter immunologischer und pharmakologischer Therapiestrategien zur Behandlung des Pankreaskarzinoms

  2006cites this paper
• Do Older Adults Using NSAIDs Have a Reduced Risk of Colorectal Cancer?

  2006cites this paper
• Can NF-kappaB be a target for novel and efficient anti-cancer agents?

  2006cites this paper
• Regular aspirin use and esophageal cancer risk

  2006cites this paper
• Diet and Gastrointestinal Cancer one-carbon metabolism and other aspects

  2006cites this paper
• Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use.

  2006cites this paper
• Single nucleotide polymorphisms in sporadic colorectal cancer

  2006cites this paper
• Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study.

  2006cites this paper
• Drug Utilization Patterns

  2005cites this paper
• Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis.

  2005cites this paper
• Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites.

  2005cites this paper
• Diclofenac attenuates Wnt/β‐catenin signaling in colon cancer cells by activation of NF‐κB

  2005cites this paper
• Repression of β-catenin function in malignant cells by nonsteroidal antiinflammatory drugs

  2005cites this paper
• Regular Analgesic Use and Risk of Endometrial Cancer

  2005cites this paper
• Use of Cyclooxygenase Inhibitors and Risk of Melanoma in High‐Risk Patients

  2005cites this paper
• COX and cancer.

  2005cites this paper
• Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma

  2005cites this paper
• Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism

  2005cites this paper
• Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway.

  2004cites this paper
• Cyclooxygenases in cancer: progress and perspective.

  2004cites this paper
• Cyclooxygenase‐2 and Gastrointestinal Cancer

  2004cites this paper
• COX-2 inhibition as a tool to treat and prevent colorectal cancer.

  2004cites this paper
• Evidence for colorectal cancer cell specificity of aspirin effects on NFκB signalling and apoptosis

  2004cites this paper
• Cell cycle arrest and modulation of HO-1 expression induced by acetyl salicylic acid in hepatocarcinogenesis.

  2004cites this paper
• Role of COX-2 Inhibitors in Cancer Therapy

  2004cites this paper
• Riesgo de cáncer colorrectal asociado a medicamentos: estudio de casos y controles

  2004cites this paper
• Utilisation du diflunisal pour le traitement du cancer

  2004cites this paper